Patents by Inventor Jonathan Vennerstrom

Jonathan Vennerstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ozonides for treating or preventing virus infections
    Patent number: 11963945
    Abstract: Described are methods of treating or preventing a virus in a subject comprising administering ozonides to the subject.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: April 23, 2024
    Assignees: THE JOHNS HOPKINS UNIVERSITY, BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Ravit Boger, Jonathan Vennerstrom
  • OZONIDES FOR TREATING OR PREVENTING VIRUS INFECTIONS
    Publication number: 20220202769
    Abstract: Described are methods of treating or preventing a virus in a subject comprising administering ozonides to the subject.
    Type: Application
    Filed: January 6, 2022
    Publication date: June 30, 2022
    Inventors: Ravit Boger, Jonathan Vennerstrom
  • Ozonides for treating or preventing virus infections
    Patent number: 11246854
    Abstract: Described are methods of treating or preventing a virus in a subject comprising administering ozonides to the subject.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: February 15, 2022
    Assignees: THE JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF NEBRASKA MEDICAL CENTER
    Inventors: Ravit Boger, Jonathan Vennerstrom
  • OZONIDES FOR TREATING OR PREVENTING VIRUS INFECTIONS
    Publication number: 20200138775
    Abstract: Described are methods of treating or preventing a virus in a subject comprising administering ozonides to the subject.
    Type: Application
    Filed: May 15, 2018
    Publication date: May 7, 2020
    Inventors: Ravit Boger, Jonathan Vennerstrom
  • CONFORMATIONALLY STABLE ANALOGS OF THE RESPONSE SELECTIVE C5A AGONIST EP67
    Publication number: 20180066018
    Abstract: Conformationally-stable peptide analogs of the response selective C5a agonist EP67 having the formula Tyr-Ser-Phe-Lys-Asp-Met-Xaa-(Xaa2)-(D-Ala)-Arg (SEQ ID NO:1), wherein Xaa is a modified proline residue or a residue substitution for proline, and Xaa2 is leucine or N-methyl leucine. The conformationally-stable peptides selectively bind and activate APCs without directly engaging/binding C5a receptor-bearing cells involved in pro-inflammatory activities of natural C5a. Compositions and methods of using the peptide analogs are also described.
    Type: Application
    Filed: March 11, 2016
    Publication date: March 8, 2018
    Inventors: Sam D. Sanderson, Jonathan Vennerstrom
  • CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS
    Publication number: 20070203076
    Abstract: The present invention describes a method for providing creatine to an animal, which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.
    Type: Application
    Filed: May 2, 2007
    Publication date: August 30, 2007
    Inventors: Jonathan Vennerstrom, Donald Miller
  • Spiro and dispiro 1,2,4-trioxolane antimalarials
    Publication number: 20050256185
    Abstract: A means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane is described. The preferred 1,2,4-trioxolanes include a spiroadamantane group on one side of the trioxolane group, and a spirocyclohexyl on the other side of the trioxolane group, whereby the spirocyclohexyl ring is preferably substituted at the 4-position. In comparison to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.
    Type: Application
    Filed: May 4, 2005
    Publication date: November 17, 2005
    Applicant: MEDICINES FOR MALARIA VENTURE MMV
    Inventors: Jonathan Vennerstrom, Yuxiang Dong, Jacques Chollet, Hugues Matile, Xiaofang Wang, Kamaraj Sriraghavan, William Charman
  • Production of creatine esters using in situ acid production
    Patent number: 6897334
    Abstract: Methods are provided for the improved production of a creatine ester by in situ production of an acid catalyst.
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: May 24, 2005
    Assignee: Board of Regents of the University of Nebraska
    Inventor: Jonathan Vennerstrom
  • Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
    Publication number: 20050089524
    Abstract: Compounds are disclosed comprising molecular adjuvants having an antigen presenting cell-targeting ligand linked to a nicotine hapten. Methods are disclosed for employing the compounds as a nicotine vaccine for treatment or prevention of nicotine addiction.
    Type: Application
    Filed: February 20, 2003
    Publication date: April 28, 2005
    Inventors: Sam Sanderson, Jonathan Vennerstrom, Geoffrey Thiele, Maniyan Parameswaran, Rick Bevins, Cheruku Srinivasa
  • Production of creatine esters using in situ acid production
    Publication number: 20050049428
    Abstract: Methods are provided for the improved production of a creatine ester by in situ production of an acid catalyst.
    Type: Application
    Filed: August 25, 2003
    Publication date: March 3, 2005
    Inventor: Jonathan Vennerstrom